Skip to main content

Day: June 19, 2020

Italeaf: la subsidiary algoWatt mette in esercizio l’impianto di bonifica acque di falda e di trattamento rifiuti liquidi industriali Purify

COMUNICATO STAMPA 19 GIUGNO 2020Italeaf: la subsidiary algoWatt mette in esercizio l’impianto di bonifica acque di falda e di trattamento rifiuti liquidi industriali Purify·Il nuovo asset ambientale è attivo in Umbria, nel parco eco-industriale di Nera Montoro (TR) ed è autorizzato al trattamento di 438.000 mc/anno di acque di falda e 58.000 ton/anno di rifiuti liquidi·Impianto di proprietà della JV Purify Srl tra algoWatt e ATP Project & Constructions, Investimento totale pari a circa Euro 9 milioniItaleaf SpA, holding di partecipazione e primo company builder italiano attivo nei settori cleantech e smart innovation, quotata al NASDAQ First North Growth Market della Borsa di Stoccolma, comunica che la subsidiary algoWatt, GreenTech Solutions Company quotata sul mercato telematico azionario (MTA) di Borsa Italiana, ha messo in esercizio...

Continue reading

BeiGene Announces Acceptance of a Supplemental New Drug Application for Tislelizumab in Combination with Chemotherapy in First-Line Advanced Non-Squamous Non-Small Cell Lung Cancer in China

BEIJING, China and CAMBRIDGE, Mass., June 19, 2020 (GLOBE NEWSWIRE) — BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted a supplemental new drug application (sNDA) of BeiGene’s anti-PD-1 antibody tislelizumab in combination with chemotherapy for first-line treatment of patients with advanced non-squamous non-small cell lung cancer (NSCLC).“We are pleased to submit our second sNDA in first-line advanced NSCLC and the fourth potential indication for tislelizumab in China. We credit the continued momentum of our tislelizumab clinical program to...

Continue reading

Kratos Defense & Security Solutions, Inc. Prices Public Offering of Common Stock

SAN DIEGO, June 18, 2020 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (“Kratos”) (Nasdaq: KTOS), a leading National Security Solutions provider, today announced the pricing of an underwritten offering of 13,500,000 shares of its common stock at a public offering price of $16.25 per share pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission (the “SEC”).  The net proceeds to Kratos from the offering, after deducting underwriting discounts and commissions, are expected to be approximately $209.0 million. Kratos has also granted the underwriters a 30-day option to purchase up to an additional 2,025,000 shares of common stock.  All of the shares in the offering are to be sold by Kratos.  The offering is expected to close on June 23, 2020, subject to customary closing...

Continue reading

CB2 Insights Announces Record Annual Revenue of $13.4 million for FY 2019 Sequential Growth of 25%

TORONTO, June 18, 2020 (GLOBE NEWSWIRE) — CB2 Insights (CSE: CBII; OTCQB: CBIIF) (“CB2” or the “Company”), one of the largest integrative healthcare system in the United States, today reported its audited consolidated financial results for the year ended December 31, 2019. Additional information concerning the Company, including its unaudited condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the year ended December 31, 2019, can be found at www.sedar.com and on the Company’s website (www.cb2insights.com). All amounts are expressed in Canadian dollars unless otherwise noted.Prad Sekar, Chief Executive Officer of CB2, stated, “2019 was a building year for the Company. Shortly after going public, we made four acquisitions, streamlined our product offering, accelerated...

Continue reading

Skyline Provides Operational Update

TORONTO, June 18, 2020 (GLOBE NEWSWIRE) — Skyline Investments Inc. (the “Company” or “Skyline”) (TASE: SKLN) provided an update regarding the effect of COVID-19 on the operations of the Company.Canadian OperationsDeerhurst Resort and Horseshoe Valley Resort have both reopened as of June 12, 2020. Summer reservations are building once again at both of the resorts, however, the Province of Ontario still has significant restrictions in place. Indoor restaurants are not allowed to be open, and gatherings are limited to 10 people. The Greater Toronto Area remains under significant restrictions and therefore only essential services are permitted to be open. These restrictions are expected to be removed gradually as COVID-19 cases reduce. Each of the resorts’ food and beverage operations are restricted to outside patio service, whose areas...

Continue reading

Grupo Aeroportuario del Pacifico Announces Temporary Closure of Tijuana Airport Due to Security Concerns

GUADALAJARA, Mexico, June 18, 2020 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacifico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announced that yesterday government officials from the State of Baja California entered the sterile area of the Tijuana International Airport. These individuals entered the premises in a violent manner that breached inspection and safety protocols.In response to this violation, the Company had to activate all safety protocols, thus resulting in the temporary closure of all airport operations for approximately 25 minutes, to ensure that there was no risk to the operation. This is in accordance with Airport Laws and Regulations, The National Civil Aviation Security Program, as well as Annex 17 and Document 8973 of the International Civil Aviation Organization (ICAO). There were no aircraft...

Continue reading

DoubleDown Interactive Announces Launch of Initial Public Offering

SEATTLE, June 18, 2020 (GLOBE NEWSWIRE) — DoubleDown Interactive Co., Ltd. (“DoubleDown”), a leading developer and publisher of digital social casino games, today announced that it has commenced the initial public offering of its American Depositary Shares (“ADSs”) representing shares of DoubleDown’s common stock. DoubleDown, together with a selling stockholder, are offering an aggregate of 11,000,000 ADSs. Every twenty ADSs represent one ordinary share. The initial public offering price is expected to be between US$17 to US$19 per ADSs. The selling stockholder expects to grant the underwriters a 30-day option to purchase up to an additional 1,650,000 ADSs at the initial public offering price. The ADSs are expected to trade on the NASDAQ Global Select Market under the ticker symbol “DDI”.J.P. Morgan Securities LLC and BofA Securities...

Continue reading

PINTEC Expands Cooperation with China Telecom Bestpay to Offer Handset Installment Services to Government and Enterprise Customers

BEIJING, June 19, 2020 (GLOBE NEWSWIRE) — Pintec Technology Holdings Ltd. (NASDAQ: PT) (“PINTEC” or the “Company”), a leading independent fintech solutions provider, today announced that it has expanded its cooperation with China Telecom Bestpay (“Bestpay”), a wholly-owned subsidiary of China Telecom Corporation Limited (“China Telecom”) and one of the largest payment platforms in China, to provide intelligent handset installment services to Bestpay’s government and enterprise customers. The Company began working with Bestpay to expand its cooperation scope in March 2020.Leveraging PINTEC’s technological expertise, Bestpay has launched its handset financing product Chengfenqi to provide individual customers with intelligent installment payment services. Both parties have decided to develop the Chengfenqi product for government and...

Continue reading

中美冠科主办创新型线上AACR 2020会议和展会

加州圣地亚哥, June 19, 2020 (GLOBE NEWSWIRE) — 中美冠科今天宣布了创新型线上AACR 2020会议。此次线上活动将于6月22至25日进行,集合了一个大型科学会议的所有要点。不仅拥有虚拟展位,还有来自冠科资深科学家的主题演讲,以及13张来自冠科AACR 2020的海报。为了与AACR年度网络会议保持一致,在这个特别的论坛中,我们将展示由中美冠科内部及与其他机构合作的13张AACR 2020海报,包括了一系列临床前肿瘤学和免疫肿瘤学主题,包括肿瘤类器官和类器官工程、成像同基因与肿瘤同种移植,以及新型的人源化药物靶点模型,海报作者将在线回答问题。此次活动免费参加, 需要在CrownBio.com/AACR20上注册。主题剧场的亮点包括中美冠科首席科学官Henry Li博士的关于使用人源肿瘤类器官加速药物发现的演讲,以及在生物标志物发现、体外药物发现的电脑模拟运用和免疫疗法毒理学评估平台等领域的进一步科学演讲。“尽管我们面临全球性的挑战,我们仍致力于推动科学探讨和药物发现。”中美冠科市场营销执行总监Gavin Cooper表示。“我们的创新活动体验旨在尽可能接近实际会议体验,能够实时访问我们的所有资源、海报和科学团队。”此次活动还设有一个科学性的线上休息室,用于提问和与我们的科学团队进行实时交流。并在展位上提供了大量中美冠科的资源,展示了包括类器官、生物标志物发现、生物信息学和人源肿瘤异体移植 (PDX)模型在内的产品和服务。此次免费活动可以在CrownBio.com/AACR20上注册。关于中美冠科中美冠科生物技术有限公司(CrownBio)隶属于JSR生命科学公司,是一家全球性的药物发现和开发公司,为推进肿瘤、炎症、心血管及代谢疾病的研究提供转化医学平台。中美冠科拥有数量庞大的相关模型库和预测工具组合,能够为客户提供优秀的临床候选药物筛选服务。有关详细信息,请访问:https://www.crownbio.comhttps://www.jsrlifesciences.comMedia...

Continue reading

Flow Announces Change of Auditor, Elevates Alex Baluta to the Board of Directors

TORONTO, June 18, 2020 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV: FW) (“Flow Capital” or the “Company“) announces that it has changed its auditors from Goodman and Associates LLP (“Former Auditor“) to Dale Matheson Carl-Hilton Labonte LLP (“Successor Auditor“). At the request of the Company, the Former Auditor resigned as the auditor of the Company effective June 9, 2020 and the board of directors of the Company appointed the Successor Auditor as the Company’s auditor effective June 9, 2020, until the next Annual General Meeting of the Company.There were no reservations or modified opinions in the Former Auditor’s audit reports for the Company. There are no “reportable events” (as the term is defined in National Instrument 51-102 – Continuous Disclosure Obligations...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.